Legal Representation
Attorney
Thomas E. Zutic
USPTO Deadlines
Next Deadline
22 days remaining
Published for Opposition
Due Date
July 31, 2025
Extension Available
Until August 31, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
14 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 25, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 31, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 30, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 17, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 17, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 17, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| May 9, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 12, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 12, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Dec 20, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials
Additional Information
Design Mark
The mark consists of stacked terms "TRIAL COMPLEXITY", "OPTIMIZER" and "BY BCG X", all to the left, and partially overlapping, a slash design.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
TRIAL COMPLEXITY OPTIMIZER BY BOSTON CONSULTING GROUP X
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
TRIAL COMPLEXITY OPTIMIZER